Global Meningococcal Vaccines Market is Predicted to Reach US$ 7,732.3 Million by the End of 2027, with a Value of US$ 3,341.9 Million

-
Meningococcal Vaccines
Meningococcal Vaccines

Meningococcal vaccination protects against diseases caused by Neisseria meningitides, often known as meningococcus, a Gram-negative bacterium that can cause meningitis and other kinds of meningococcal disease such as meningococcemia.

Drivers of the Global Meningococcal Vaccine Market

Over the projected period, a large number of people traveling to Sub-Saharan Africa is expected to drive the global Meningococcal Vaccines Market. In 2017, for example, 37.4 million tourists visited Sub-Saharan Africa, according to the World Economic Forum's 2018 report. Furthermore, the industry is likely to benefit from the recommendations of several regulatory authorities for a meningococcal vaccine. Meningococcal vaccines, for example, are recommended by the Centers for Disease Control and Prevention for preteens, teens, and certain other persons.

Restraints in the Global Meningococcal Vaccine Market

Both regionally and across time, significant changes in meningococcal illness incidence and epidemiology have been reported. As a result, comprehensive coverage addressing as many serogroups as possible is required. Because the risk associated with traveling is unexpected, providing evidence-based vaccine recommendations is more difficult. Such a scenario is likely to stifle market expansion. Furthermore, in several countries, Meningococcal Vaccines Market is optional, which is projected to impede the market growth.

Meningococcal Vaccines Market: Opportunities

The development of vaccines that do not require extremely restricted temperature ranges for storage is projected to provide attractive growth prospects for market players. Only one meningococcal vaccination, MenAfriVac, has been authorized for use outside of the cold chain yet. Meningococcal Vaccines Market Growth is also likely to be aided by the development of vaccines through collaborations and public-private partnerships. The PATH-WHO Meningitis Vaccine Project, an Indian vaccine maker Serum Institute of India Ltd., and public health experts in India and numerous African countries collaborated to develop the novel MenAfriVac meningococcal vaccine. In the African meningitis belt, the development was intended at delivering an effective, long-term, and economical solution to outbreaks caused by meningococcal illness.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more